Impact of Guideline-Based Acute Kidney Injury Care Processes on Outcomes in Hospitalized Patients With Decompensated Cirrhosis

GOALS: We evaluated whether adherence to acute kidney injury (AKI) specific process measures (PMs) improves outcomes in hospitalized patients with cirrhosis and AKI. BACKGROUND: Expert bodies recommend PMs for the management of AKI in cirrhosis, but the link between PMs and outcomes is unclear. STUDY: We performed a retrospective cohort study of patients hospitalized with ascites and AKI at Veterans Administration hospitals. We examined the relationship between PMs [avoidance of diuretics, nonselective beta-blockers (NSBB), and other vasodilators, volume expansion with albumin/crystalloids, infectious work-up, subspecialty consultation, and postdischarge outpatient visit] and patient outcomes. Outcomes were in-hospital AKI resolution and 90-day mortality, adjusted for patient demographics, comorbidities, cirrhosis complications, Model for End-Stage Liver Disease (MELD) 3.0 score, and AKI stage. RESULTS: Among 2221 patients, adherence to PMs varied: NSBB, diuretics, and other vasodilators were avoided in 97%, 79%, and 80% of cases, respectively. Volume expansion with albumin and crystalloids was administered in 21% and 29% of cases, while 47% had an infectious workup and 29% had subspecialty consultation. Postdischarge follow-up rates within 15 days were low: 28% for primary care, 6% for gastroenterology/hepatology, and 1% for nephrology. Overall, 53% achieved AKI resolution, and 40% died within 90 days. Diuretic avoidance was associated with increased likelihood of AKI resolution (OR: 1.14, 95% CI: 1.02-1.28). Timely postdischarge outpatient visits with primary care [hazard ratio (HR): 0.53, 95% CI: 0.43-0.67] or gastroenterology/hepatology (HR: 0.44, 95% CI: 0.29-0.66) were independently associated with reduced 90-day mortality risk. CONCLUSION: Targeting specific PMs, especially diuretic avoidance and timely postdischarge outpatient visit, may improve outcomes in cirrhosis-associated AKI.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Gastroenterology
Published
2026-11-13
DOI
https://doi.org/10.1097/mcg.0000000000002469
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of Guideline-Based Acute Kidney Injury Care Processes on Outcomes in Hospitalized Patients With Decompensated Cirrhosis

Giuseppe Cullaro, Rubén Hernáez, Andrew S. Allegretti, Elsa Solà et al.
4 links
Journal of Clinical Gastroenterology
Liver Disease and Transplantation
article

Impact of Guideline-Based Acute Kidney Injury Care Processes on Outcomes in Hospitalized Patients With Decompensated Cirrhosis

Giuseppe Cullaro, Rubén Hernáez, Andrew S. Allegretti, Elsa Solà, Kavish Rohit Patidar, George T. Cholankeril, Nikhilesh R. Mazumder, Jennifer R. Kramer, Nagasri Shankar, Prasun K. Jalal, Avegail G. Flores, Fasiha Kanwal, Thom Taylor, Yan Liu
article en

Abstract

GOALS: We evaluated whether adherence to acute kidney injury (AKI) specific process measures (PMs) improves outcomes in hospitalized patients with cirrhosis and AKI. BACKGROUND: Expert bodies recommend PMs for the management of AKI in cirrhosis, but the link between PMs and outcomes is unclear. STUDY: We performed a retrospective cohort study of patients hospitalized with ascites and AKI at Veterans Administration hospitals. We examined the relationship between PMs [avoidance of diuretics, nonselective beta-blockers (NSBB), and other vasodilators, volume expansion with albumin/crystalloids, infectious work-up, subspecialty consultation, and postdischarge outpatient visit] and patient outcomes. Outcomes were in-hospital AKI resolution and 90-day mortality, adjusted for patient demographics, comorbidities, cirrhosis complications, Model for End-Stage Liver Disease (MELD) 3.0 score, and AKI stage. RESULTS: Among 2221 patients, adherence to PMs varied: NSBB, diuretics, and other vasodilators were avoided in 97%, 79%, and 80% of cases, respectively. Volume expansion with albumin and crystalloids was administered in 21% and 29% of cases, while 47% had an infectious workup and 29% had subspecialty consultation. Postdischarge follow-up rates within 15 days were low: 28% for primary care, 6% for gastroenterology/hepatology, and 1% for nephrology. Overall, 53% achieved AKI resolution, and 40% died within 90 days. Diuretic avoidance was associated with increased likelihood of AKI resolution (OR: 1.14, 95% CI: 1.02-1.28). Timely postdischarge outpatient visits with primary care [hazard ratio (HR): 0.53, 95% CI: 0.43-0.67] or gastroenterology/hepatology (HR: 0.44, 95% CI: 0.29-0.66) were independently associated with reduced 90-day mortality risk. CONCLUSION: Targeting specific PMs, especially diuretic avoidance and timely postdischarge outpatient visit, may improve outcomes in cirrhosis-associated AKI.

Journal of Clinical Gastroenterology
Houston Methodist (US), Michael E. DeBakey VA Medical Center (US), Baylor College of Medicine (US), University of Michigan (US), Massachusetts General Hospital (US), Stanford Medicine (US), Stanford University (US)
Good health and well-being
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon